On February 22, 2024, Biofrontera Inc., closed the transaction. The company has received $8,000,000 as gross proceeds from 8 investors pursuant to Regulation D.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.33 USD | -15.82% | -21.58% | -51.30% |
18/03 | Transcript : Biofrontera Inc., Q4 2023 Earnings Call, Mar 18, 2024 | |
15/03 | Biofrontera Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-51.30% | 8.04M | |
+32.91% | 695B | |
+26.51% | 568B | |
-4.62% | 361B | |
+19.84% | 330B | |
+3.76% | 283B | |
+16.74% | 239B | |
+8.30% | 204B | |
-7.81% | 198B | |
+8.50% | 168B |
- Stock Market
- Equities
- BFRI Stock
- News Biofrontera Inc.
- Biofrontera Inc. announced that it has received $8 million in funding